We recommended laboratories implement the National Institutes of Health (NIH) equation,
to replace the Friedewald equation, for calculating low-density lipoprotein cholesterol
(LDL-C) in all patients.
1
In response, Cartier et al. argue that as LDL-C is an inferior marker to non–high-density
lipoprotein cholesterol (non-HDL-C) and apolipoprotein B (apoB) for atherogenicity
when triglycerides (TG) > 1.50 mmol/L, LDL-C calculation should be omitted when not
pertinent. We agree that non–HDL-C and apoB are superior when TG is elevated; however,
it is still important to clinically report accurate LDL-C values, when possible.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Canadian Society of Clinical Chemists harmonized clinical laboratory lipid reporting recommendations on the basis of the 2021 Canadian Cardiovascular Society Lipid Guidelines.Can J Cardiol. 2022; 38: 1180-1188
- A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia.JAMA Cardiol. 2020; 5: 540-548
- Canadian Cardiovascular Society position statement on familial hypercholesterolemia: update 2018.Can J Cardiol. 2018; 34: 1553-1563
- 2021 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult.Can J Cardiol. 2021; 37: 1129-1150
Article info
Publication history
Published online: November 25, 2022
Accepted:
November 20,
2022
Received:
November 18,
2022
Identification
Copyright
© 2022 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Calculated LDL-C: Time to Move On?Canadian Journal of CardiologyVol. 39Issue 3
- PreviewDespite its shortcomings, the Friedewald equation is still being used today in most clinical laboratories to calculate low-density lipoprotein-cholesterol (LDL-C). Updated equations have been proposed to circumvent some of the problems of LDL-C calculation. A recent article by White-Al Habeeb et al.1 in this journal recommended implementation of the new National Institutes of Health (NIH) equation2 rather than the Friedewald calculation. The authors stated that the new NIH equation “allows for calculation of LDL-C up to triglyceride 9.04 mmol/L.”
- Full-Text
- Preview
- Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of the 2021 Canadian Cardiovascular Society Lipid GuidelinesCanadian Journal of CardiologyVol. 38Issue 8
- PreviewThere is limited guidance on laboratory reporting and interpretation of lipids and lipoproteins used in cardiovascular risk stratification. This contributes to inconsistencies in lipid reporting across clinical laboratories. Recently, the Canadian Cardiovascular Society (CCS) published the 2021 CCS guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. A subcommittee of the Working Group on Reference Interval Harmonization of the Canadian Society of Clinical Chemists has developed harmonized lipid reporting recommendations that are aligned with the 2021 CCS guidelines, to improve the standardization of lipid assessment and clinical decision-making.
- Full-Text
- Preview
